Patents by Inventor Mayumi Takano

Mayumi Takano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240293402
    Abstract: The present invention provides a pharmaceutical composition having excellent dissolution property and content uniformity and a production method thereof by mixing a p-toluenesulfonate of 7-[[2,3-difluoro-4-[2-[2-methoxyethyl(methyl)amino]ethoxy]phenyl]methyl]-10-hydroxy-6-methyl-8-oxo-N-[4-(trifluoromethyl)-2-[6-(trifluoromethyl)pyrimidin-4-yl]phenyl]-6,7-diazaspiro[4,5]deca-9-ene-9-carboxamide with specific additives, and formulating the mixture.
    Type: Application
    Filed: June 8, 2022
    Publication date: September 5, 2024
    Inventors: Kenichi SAKAI, Hiromasa UCHIYAMA, Tomoyuki MINODA, Mayumi YOSHIKAWA, Shigemori NATSUMOTO, Ryusuke TAKANO
  • Publication number: 20230358727
    Abstract: The visualization method of the present invention includes the steps of: visualizing a first substance capable of binding to a target substance in a specimen; and visualizing a second substance produced by action of the first substance in the specimen.
    Type: Application
    Filed: November 24, 2020
    Publication date: November 9, 2023
    Inventors: HIROSHI NEGISHI, NAOKO FURUSAWA, YASUSHI NAKANO, KOHSUKE GONDA, NARUFUMI KITAMURA, MAYUMI TAKANO
  • Patent number: 8158640
    Abstract: A novel compound of the formula (I): wherein R1 is alkoxycarbonyl or the like, R2 is alkyl or the like; R3 is hydrogen or the like; R4 is alkylene or the like; R5 is optionally substituted heterocyclic group; R6, R7, R8 and R9 are independently hydrogen; alkyl, alkoxy, or the like; R10 is optionally substituted aromatic ring, or the like; or a pharmaceutically acceptable salt thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP).
    Type: Grant
    Filed: October 25, 2010
    Date of Patent: April 17, 2012
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Hitoshi Kubota, Masakatsu Sugahara, Mariko Furukawa, Mayumi Takano, Daisuke Motomura
  • Publication number: 20110039828
    Abstract: A novel compound of the formula (I): wherein R1 is alkoxycarbonyl or the like, R2 is alkyl or the like; R3 is hydrogen or the like; R4 is alkylene or the like; R5 is optionally substituted heterocyclic group; R6, R7, R8 and R9 are independently hydrogen; alkyl, alkoxy, or the like; R10 is optionally substituted aromatic ring, or the like; or a pharmaceutically acceptable salt thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP).
    Type: Application
    Filed: October 25, 2010
    Publication date: February 17, 2011
    Inventors: Hitoshi KUBOTA, Masakatsu Sugahara, Mariko Furukawa, Mayumi Takano, Daisuke Motomura
  • Patent number: 7872126
    Abstract: A novel compound of the formula (I): wherein R1 is alkoxycarbonyl or the like, R2 is alkyl or the like; R3 is hydrogen or the like; R4 is alkylene or the like; R5 is optionally substituted heterocyclic group; R6, R7, R8 and R9 are independently hydrogen; alkyl, alkoxy, or the like; R10 is optionally substituted aromatic ring, or the like; or a pharmaceutically acceptable salt thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP).
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: January 18, 2011
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Hitoshi Kubota, Masakatsu Sugahara, Mariko Furukawa, Mayumi Takano, Daisuke Motomura
  • Publication number: 20070082896
    Abstract: A novel compound of the formula (I): wherein R1 is alkoxycarbonyl or the like, R2 is alkyl or the like; R3 is hydrogen or the like; R4 is alkylene or the like; R5 is optionally substituted heterocyclic group; R6, R7, R8 and R9 are independently hydrogen; alkyl, alkoxy, or the like; R10 is optionally substituted aromatic ring, or the like; or a pharmaceutically acceptable salt thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP).
    Type: Application
    Filed: September 27, 2006
    Publication date: April 12, 2007
    Inventors: Hitoshi Kubota, Masakatsu Sugahara, Mariko Furukawa, Mayumi Takano, Daisuke Motomura